ACAD ACADIA Pharmaceuticals

Watchlist

16.490
+0.170+1.04%

Trading Apr 2 11:42 ET

2.75BMarket Cap12.13P/E (TTM)

About ACADIA Pharmaceuticals Company

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Company Profile

SymbolACAD

Company NameACADIA Pharmaceuticals

Listing DateMay 27, 2004

Issue Price7.00

Founded1993

CEOMs. Catherine Owens Adams

MarketNASDAQ

Employees654

Fiscal Year Ends12-31

Address12830 El Camino Real,Suite 400

CitySan Diego

ProvinceCalifornia

CountryUnited States of America

Zip Code92130-3331

Phone1-858-558-2871

Websitehttp://www.acadia.com

Company Executives

Name
Position
Salary

Catherine Owens Adams
Director and Chief Executive Officer
--

Jennifer J. Rhodes
Executive Vice President, Chief Legal Officer and Secretary
--

Mark C. Schneyer
Executive Vice President and Chief Financial Officer
2.59M

James K. Kihara
Senior Vice President, Finance, Controller and Chief Accounting Officer
--

Dr. Elizabeth H.Z. Thompson, PhD
Executive Vice President and Head of Research and Development
--

Dr. Stephen R. Biggar,M.D.,PhD
Chairman of the Board
432.75K

Laura A. Brege
Independent Director
392.75K

Julian C. Baker
Independent Director
377.75K

James F. Daly
Independent Director
--

Daniel B. Soland
Independent Director
387.75K

Dr. Elizabeth A. Garofalo, M.D.
Independent Director
377.75K

Dr. Edmund P. Harrigan, M.D.
Independent Director
387.75K

Dr. Adora Ndu, Pharm.D.
Independent Director
377.75K

ACAD ACADIA Pharmaceuticals

About ACADIA Pharmaceuticals Company

Company Profile

Company Executives

Market Insights

Latest News

Discussing

focus on technology stocks

Investment Course